Adagene Price To Sales Ratio from 2010 to 2024
| ADAG Stock | USD 2.27 0.08 3.65% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 4.61478057 | Current Value 4.38 | Quarterly Volatility 771.70865585 |
Check Adagene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adagene's main balance sheet or income statement drivers, such as Tax Provision of 1.8 M, Net Interest Income of 3.3 M or Interest Income of 4.5 M, as well as many indicators such as Price To Sales Ratio of 4.38, Dividend Yield of 0.0 or PTB Ratio of 1.24. Adagene financial statements analysis is a perfect complement when working with Adagene Valuation or Volatility modules.
Adagene | Price To Sales Ratio |
Latest Adagene's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Adagene over the last few years. Price to Sales Ratio is figured by comparing Adagene stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Adagene sales, a figure that is much harder to manipulate than other Adagene multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Adagene's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Adagene's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 123.19 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Adagene Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 742.90 | |
| Geometric Mean | 246.91 | |
| Coefficient Of Variation | 103.88 | |
| Mean Deviation | 462.07 | |
| Median | 682.80 | |
| Standard Deviation | 771.71 | |
| Sample Variance | 595,534 | |
| Range | 2.8K | |
| R-Value | (0.13) | |
| Mean Square Error | 631,038 | |
| R-Squared | 0.02 | |
| Significance | 0.65 | |
| Slope | (21.87) | |
| Total Sum of Squares | 8.3M |
Adagene Price To Sales Ratio History
About Adagene Financial Statements
Adagene stakeholders use historical fundamental indicators, such as Adagene's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Adagene investors may analyze each financial statement separately, they are all interrelated. For example, changes in Adagene's assets and liabilities are reflected in the revenues and expenses on Adagene's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Adagene. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 4.61 | 4.38 |
Currently Active Assets on Macroaxis
When determining whether Adagene is a strong investment it is important to analyze Adagene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adagene's future performance. For an informed investment choice regarding Adagene Stock, refer to the following important reports:Check out the analysis of Adagene Correlation against competitors. For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adagene. If investors know Adagene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adagene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.72) | Revenue Per Share 0.019 | Quarterly Revenue Growth (0.85) | Return On Assets (0.20) | Return On Equity (0.46) |
The market value of Adagene is measured differently than its book value, which is the value of Adagene that is recorded on the company's balance sheet. Investors also form their own opinion of Adagene's value that differs from its market value or its book value, called intrinsic value, which is Adagene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adagene's market value can be influenced by many factors that don't directly affect Adagene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adagene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adagene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adagene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.